Epitome Therapeutics

Epitome Therapeutics is a biotech company in Vienna, Austria, founded in 2025. It has raised $6.6M across 2 rounds, most recently a $2.2M Grant in June 2026.

Epitome Therapeutics FlexCo

Headquarters
Vienna
Employees
1–10
Founded
2025
Business Model
B2B
Total Funding
$6.6M
Last Round
$2.2M GrantJun 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Epitome Therapeutics is a Vienna-based biotechnology company developing a proprietary epigenome editing platform called CADENCE, designed to achieve precise, durable activation of gene expression without altering DNA sequence. Founded in 2025 as a spin-off from the European Molecular Biology Laboratory (EMBL) in Rome by co-founders Dr. Guido Gualdoni (CEO) and Dr. Jamie Hackett (CSO), the company focuses on diseases requiring restoration or fine-tuning of gene activity. Epitome raised €4M in total pre-seed financing co-led by XISTA Science Ventures and Caesar Ventures to advance its first drug candidate selection.

Summary

It lists 1–10 employees. It has raised $6.6M in total across 2 rounds, most recently a $2.2M Grant round in Jun 2026.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantJun 2026
$2.2M

Sign up to see all 2 events

Funding: Grant through Pre-Seed. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Epitome Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/epitome-therapeutics"><img src="https://indexed.vc/api/badge/company/epitome-therapeutics" alt="Epitome Therapeutics on Indexed.vc" width="260" height="76" /></a>